EANM Dosimetry Committee guidance document: good practice of clinical dosimetry reporting


DOI: 10.1007/s00259-010-1549-3

Cite this article as:
Lassmann, M., Chiesa, C., Flux, G. et al. Eur J Nucl Med Mol Imaging (2011) 38: 192. doi:10.1007/s00259-010-1549-3


Many recent publications in nuclear medicine contain data on dosimetric findings for existing and new diagnostic and therapeutic agents. In many of these articles, however, a description of the methodology applied for dosimetry is lacking or important details are omitted. The intention of the EANM Dosimetry Committee is to guide the reader through a series of suggestions for reporting dosimetric approaches. The authors are aware of the large amount of data required to report the way a given clinical dosimetry procedure was implemented. Another aim of this guidance document is to provide comprehensive information for preparing and submitting publications and reports containing data on internal dosimetry. This guidance document also contains a checklist which could be useful for reviewers of manuscripts submitted to scientific journals or for grant applications. In addition, this document could be used to decide which data are useful for a documentation of dosimetry results in individual patient records. This may be of importance when the approval of a new radiopharmaceutical by official bodies such as EMA or FDA is envisaged.


Dosimetry Targeted radiotherapy Reporting 

Supplementary material

259_2010_1549_MOESM1_ESM.pdf (17 kb)
ESM(PDF 16.7 KB)

Copyright information

© EANM 2010

Authors and Affiliations

  1. 1.Department of Nuclear MedicineUniversity of WürzburgWürzburgGermany
  2. 2.Nuclear Medicine UnitFoundation IRCCS Istituto Nazionale TumoriMilanItaly
  3. 3.Joint Department of PhysicsRoyal Marsden Hospital & Institute of Cancer ResearchLondonUK
  4. 4.INSERM, UMR892 – Centre de Recherche en CancérologieNantesFrance

Personalised recommendations